Annals of Oncology 10:637-645, 1999
© 1999 European Society for Medical Oncology
research-article |
Gastric MALT lymphoma: From concept to cure
Department of Histopathology, Royal Free and University College Medical School London, UK
P. G. Isaacson, MD, Department of Histopathology, Royal Free and University College Medical School, London WC1E6JJ, UK E-mail: s.slaymark{at}ucl.ac.uk
Gastric MALT lymphomas are clinically and histologically quite distinct from comparable low-grade B-cell lymphomas of lymph nodes. Their histology suggests that immunological mechanisms might be operative in their growth. Given that there is normally no lymphoid tissue in gastric mucosa and that Helicobacter pylori (H pylori), the only common bacterial antigen in the stomach, results in the accumulation of gastric MALT, the possibility that this organism is implicated in the pathogenesis of gastric lymphoma has been extensively investigated. It appears that most, but not necessarily all, gastric MALT lymphomas arise in MALT acquired in response to H. pylori infection and develop by stepwise accumulation of genetic abnormalities. Early molecular events in the evolution of gastric MALT lymphoma from acquired MALT include trisomy 3, t(11;18)(q21;q21), genetic damage leading to genetic instability, as indicated by the so-called replication error repair (RER) phenotype, and both p53 and c-myc mutations. At this stage in their development, the growth of the lymphomas is driven by contact between the neoplastic B cells and H. pylori specific intra-tumoral T cells. Eradication of H. pylori causes the tumour to enter a latent phase resulting in clinical regression. Later events, such as t(l;14)(p22;q32), appear to be linked to a capacity for autonomous growth, loss of sensitivity to H. pylori and dissemination of the lymphoma beyond the stomach and gastric lymph nodes. Cloning of the breakpoint in t(1;14) has allowed the identification of a new tumour suppresser gene, bcllO. High grade transformation of MALT lymphoma has been associated with p53 inactivation, deletions of p16 and t(8;14).
gastric lymphoma, H. pylori, MALT lymphoma
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. J. A. Deutsch, A. Aigelsreiter, P. B. Staber, A. Beham, W. Linkesch, C. Guelly, R. I. Brezinschek, M. Fruhwirth, W. Emberger, M. Buettner, et al. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation Blood, April 15, 2007; 109(8): 3500 - 3504. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Cohen, M. Petryk, M. Varma, P. S. Kozuch, E. D. Ames, and M. L. Grossbard Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue Oncologist, November 1, 2006; 11(10): 1100 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Streubel, D. Huber, S. Wohrer, A. Chott, and M. Raderer Reverse Transcription-PCR for t(11;18)(q21;q21) Staging and Monitoring in Mucosa-Associated Lymphoid Tissue Lymphoma. Clin. Cancer Res., October 15, 2006; 12(20): 6023 - 6028. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Chen, X.-T. Hu, A. C. Liang, W.-Y. Au, C.-C. So, M. L. Wong, L. Shen, Q. Tao, K.-M. Chu, Y.-L. Kwong, et al. High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma Blood, October 1, 2006; 108(7): 2373 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hassler, C. Ramsey, M. C. Karlsson, D. Larsson, B. Herrmann, B. Rozell, M. Backheden, L. Peltonen, O. Kampe, and O. Winqvist Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma Blood, September 15, 2006; 108(6): 1941 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Raderer, B Streubel, S Wohrer, M Hafner, and A Chott Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas Gut, May 1, 2006; 55(5): 616 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. M. Ferreri, E. Viale, M. Guidoboni, A. G. Resti, C. De Conciliis, L. Politi, A. A. Lettini, F. Sacchetti, R. Dolcetti, C. Doglioni, et al. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa Ann. Onc., May 1, 2006; 17(5): 769 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Grunberger, W. Hauff, J. Lukas, S. Wohrer, C. C. Zielinski, B. Streubel, A. Chott, and M. Raderer 'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa Ann. Onc., March 1, 2006; 17(3): 484 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Salar, J. M. Ramon, C. Barranco, M. Nieto, M. Prats, S. Serrano, and C. Besses Double Diagnosis in Cancer Patients and Cutaneous Reaction Related to Gemcitabine: CASE 1. Synchronous Mucosa-Associated Lymphoid Tissue Lymphoma and Gastrointestinal Stromal Tumors of the Stomach J. Clin. Oncol., October 1, 2005; 23(28): 7221 - 7223. [Full Text] [PDF] |
||||
![]() |
P. Koch, A. Probst, W. E. Berdel, N. A. Willich, G. Reinartz, J. Brockmann, R. Liersch, F. del Valle, H. Clasen, C. Hirt, et al. Treatment Results in Localized Primary Gastric Lymphoma: Data of Patients Registered Within the German Multicenter Study (GIT NHL 02/96) J. Clin. Oncol., October 1, 2005; 23(28): 7050 - 7059. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mueller, J. O'Rourke, P. Chu, A. Chu, M. F. Dixon, D. M. Bouley, A. Lee, and S. Falkow The Role of Antigenic Drive and Tumor-Infiltrating Accessory Cells in the Pathogenesis of Helicobacter-Induced Mucosa-Associated Lymphoid Tissue Lymphoma Am. J. Pathol., September 1, 2005; 167(3): 797 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Montalban, A. Santon, C. Redondo, M. Garcia-Cosio, D. Boixeda, E. Vazquez-Sequeiros, F. Norman, C. M. de Argila, I. Alvarez, V. Abraira, et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study Ann. Onc., September 1, 2005; 16(9): 1539 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.M. Ferreri, M. Ponzoni, M. Guidoboni, C. De Conciliis, A. G. Resti, B. Mazzi, A. A. Lettini, J. Demeter, S. Dell'Oro, C. Doglioni, et al. Regression of Ocular Adnexal Lymphoma After Chlamydia Psittaci-Eradicating Antibiotic Therapy J. Clin. Oncol., August 1, 2005; 23(22): 5067 - 5073. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raderer, B. Streubel, S. Woehrer, A. Puespoek, U. Jaeger, M. Formanek, and A. Chott High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up Clin. Cancer Res., May 1, 2005; 11(9): 3349 - 3352. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Kuo, L.-T. Chen, K.-H. Yeh, M.-S. Wu, H.-C. Hsu, P.-Y. Yeh, T.-L. Mao, C.-L. Chen, S.-L. Doong, J.-T. Lin, et al. Nuclear Expression of BCL10 or Nuclear Factor Kappa B Predicts Helicobacter pylori-Independent Status of Early-Stage, High-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphomas J. Clin. Oncol., September 1, 2004; 22(17): 3491 - 3497. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Messmer, E. Albesiano, D. G. Efremov, F. Ghiotto, S. L. Allen, J. Kolitz, R. Foa, R. N. Damle, F. Fais, D. Messmer, et al. Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia J. Exp. Med., August 16, 2004; 200(4): 519 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wohrer, A. Puspok, J. Drach, M. Hejna, A. Chott, and M. Raderer Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma Ann. Onc., July 1, 2004; 15(7): 1086 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Jaffe Common Threads of Mucosa-Associated Lymphoid Tissue Lymphoma Pathogenesis: From Infection to Translocation J Natl Cancer Inst, April 21, 2004; 96(8): 571 - 573. [Full Text] [PDF] |
||||
![]() |
A. J. M. Ferreri, M. Guidoboni, M. Ponzoni, C. De Conciliis, S. Dell'Oro, K. Fleischhauer, L. Caggiari, A. A. Lettini, E. Dal Cin, R. Ieri, et al. Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas J Natl Cancer Inst, April 21, 2004; 96(8): 586 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Streubel, D. Huber, S. Wohrer, A. Chott, and M. Raderer Frequency of Chromosomal Aberrations Involving MALT1 in Mucosa-Associated Lymphoid Tissue Lymphoma in Patients with Sjogren's Syndrome Clin. Cancer Res., January 15, 2004; 10(2): 476 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Pileri, P. L. Zinzani, P. Went, A. Pileri Jr, and M. Bendandi Indolent lymphoma: the pathologist's viewpoint Ann. Onc., January 1, 2004; 15(1): 12 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wohrer, J. Drach, M. Hejna, W. Scheithauer, A. Dirisamer, A. Puspok, A. Chott, and M. Raderer Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP) Ann. Onc., December 1, 2003; 14(12): 1758 - 1761. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Aljurf, T. W. Owaidah, A. Ezzat, E. Ibrahim, and A. Tbakhi Antigen- and/or immune-driven lymphoproliferative disorders Ann. Onc., November 1, 2003; 14(11): 1595 - 1606. [Full Text] [PDF] |
||||
![]() |
A. Mueller, J. O'Rourke, P. Chu, C. C. Kim, P. Sutton, A. Lee, and S. Falkow Protective immunity against Helicobacter is characterized by a unique transcriptional signature PNAS, October 14, 2003; 100(21): 12289 - 12294. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sanchez-Izquierdo, G. Buchonnet, R. Siebert, R. D. Gascoyne, J. Climent, L. Karran, M. Marin, D. Blesa, D. Horsman, A. Rosenwald, et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma Blood, June 1, 2003; 101(11): 4539 - 4546. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Kaneko, S Sakurai, M Hironaka, S Sato, S Oguni, Y Sakuma, K Sato, K Sugano, and K Saito Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas Gut, May 1, 2003; 52(5): 641 - 646. [Abstract] [Full Text] |
||||
![]() |
M M Alsolaiman, G Bakis, T Nazeer, R P MacDermott, and J A Balint Five years of complete remission of gastric diffuse large B cell lymphoma after eradication of Helicobacter pylori infection Gut, April 1, 2003; 52(4): 507 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zucca, A. Conconi, E. Pedrinis, S. Cortelazzo, T. Motta, M. K. Gospodarowicz, B. J. Patterson, A. J. M. Ferreri, M. Ponzoni, L. Devizzi, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue Blood, April 1, 2003; 101(7): 2489 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mueller, J. O'Rourke, J. Grimm, K. Guillemin, M. F. Dixon, A. Lee, and S. Falkow Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma PNAS, February 4, 2003; 100(3): 1292 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Park, K. W. Kim, J.-S. Yu, C. Park, J. K. Kim, S.-W. Yoon, K.-H. Lee, Y. H. Ryu, H. Kim, M.-J. Kim, et al. Radiographic Findings of Primary B-Cell Lymphoma of the Stomach: Low-Grade Versus High-Grade Malignancy in Relation to the Mucosa-Associated Lymphoid Tissue Concept Am. J. Roentgenol., November 1, 2002; 179(5): 1297 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhu, J. Orchard, D. G. Oscier, D. H. Wright, and F. K. Stevenson VH gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo Blood, September 18, 2002; 100(7): 2659 - 2661. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jager, P. Neumeister, R. Brezinschek, T. Hinterleitner, W. Fiebiger, M. Penz, H. J. Neumann, B. Mlineritsch, M. DeSantis, F. Quehenberger, et al. Treatment of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type With Cladribine: A Phase II Study J. Clin. Oncol., September 15, 2002; 20(18): 3872 - 3877. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raderer, A. Chott, J. Drach, C. Montalban, B. Dragosics, U. Jager, A. Puspok, C. Osterreicher, and C. C. Zielinski Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary? Ann. Onc., July 1, 2002; 13(7): 1094 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Stolte, E Bayerdorffer, A Morgner, B Alpen, T Wundisch, C Thiede, and A Neubauer Helicobacter and gastric MALT lymphoma Gut, May 1, 2002; 50(90003): iii19 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Casato, C. Mecucci, V. Agnello, M. Fiorilli, G. B. Knight, C. Matteucci, L. Gao, and J. Kay Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia Blood, March 15, 2002; 99(6): 2259 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Connors, E. D. Hsi, and F. M. Foss Lymphoma of the Skin Hematology, January 1, 2002; 2002(1): 263 - 282. [Abstract] [Full Text] |
||||
![]() |
L.-T. Chen, J.-T. Lin, R.-Y. Shyu, C.-M. Jan, C.-L. Chen, I-P. Chiang, S.-M. Liu, I.-J. Su, and A.-L. Cheng Prospective Study of Helicobacter pylori Eradication Therapy in Stage IE High-Grade Mucosa-Associated Lymphoid Tissue Lymphoma of the Stomach J. Clin. Oncol., November 15, 2001; 19(22): 4245 - 4251. [Abstract] [Full Text] |
||||
![]() |
P Sutton, S J Danon, M Walker, L J Thompson, J Wilson, T Kosaka, and A Lee Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study Gut, October 1, 2001; 49(4): 467 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koch, F. del Valle, W. E. Berdel, N. A. Willich, B. Reers, W. Hiddemann, B. Grothaus-Pinke, G. Reinartz, J. Brockmann, A. Temmesfeld, et al. Primary Gastrointestinal Non-Hodgkin's Lymphoma: II. Combined Surgical and Conservative or Conservative Management Only in Localized Gastric Lymphoma--Results of the Prospective German Multicenter Study GIT NHL 01/92 J. Clin. Oncol., September 15, 2001; 19(18): 3874 - 3883. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cavalli, P. G. Isaacson, R. D. Gascoyne, and E. Zucca MALT Lymphomas Hematology, January 1, 2001; 2001(1): 241 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sisson, J.-Y. Jeong, A. Goodwin, L. Bryden, N. Rossler, S. Lim-Morrison, A. Raudonikiene, D. E. Berg, and P. S. Hoffman Metronidazole Activation Is Mutagenic and Causes DNA Fragmentation in Helicobacter pylori and in Escherichia coli Containing a Cloned H. pylori rdxA+ (Nitroreductase) Gene J. Bacteriol., September 15, 2000; 182(18): 5091 - 5096. [Abstract] [Full Text] |
||||
![]() |
E. Zucca, F. Bertoni, E. Roggero, and F. Cavalli The gastric marginal zone B-cell lymphoma of MALT type Blood, July 15, 2000; 96(2): 410 - 419. [Full Text] [PDF] |
||||
![]() |
G. Pinotti, C. Chini, and C. Capella Most Gastric Low-Grade B-Cell Lymphomas of Mucosa-Associated Lymphoid Tissue Persist after Helicobacter pylori Eradication Ann Intern Med, May 16, 2000; 132(10): 846 - 846. [Full Text] [PDF] |
||||
![]() |
E. Macintyre, D. Willerford, and S. W. Morris Non-Hodgkin's Lymphoma: Molecular Features of B Cell Lymphoma Hematology, January 1, 2000; 2000(1): 180 - 204. [Abstract] [Full Text] [PDF] |
||||













